These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6937171)

  • 1. Residual marrow damage from cytotoxic drugs.
    Morley A
    Aust N Z J Med; 1980 Oct; 10(5):569-71. PubMed ID: 6937171
    [No Abstract]   [Full Text] [Related]  

  • 2. The problem of permanent bone marrow damage after cytotoxic drug treatment.
    Lohrmann HP
    Oncology; 1984; 41(3):180-4. PubMed ID: 6374556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of DNA on recovery of the hematopoiesis in mice with myelosan-induced hypoplasia].
    Luzanov VM; Rogacheva SA; Shagalov LB; Vaĭnberg IuP
    Biull Eksp Biol Med; 1982 Jan; 93(1):84-7. PubMed ID: 7066509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol and cytotoxic drugs. Interaction in relation to bone marrow depression. Boston Collaborative Drug Surveillance Program.
    JAMA; 1974 Mar; 227(9):1036-40. PubMed ID: 4405931
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma.
    Fried W; Kedo A; Barone J
    Cancer Res; 1977 Apr; 37(4):1205-9. PubMed ID: 321118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review on experimental studies of Chinese drugs in antagonizing bone marrow inhibition caused by chemicals].
    Yang T; Deng D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug; 19(8):506-8. PubMed ID: 11783234
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone marrow depression following oncologic therapy].
    Schwamborn J; Pfreundschuh M
    Gynakologe; 1992 Apr; 25(2):71-5. PubMed ID: 1612521
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow regeneration under cytotoxic drug regimens: behaviour ranging from homeostasis to unpredictability in a model for hemopoietic differentiation.
    Mehr R; Agur Z
    Biosystems; 1992; 26(4):231-7. PubMed ID: 1627734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term consequences of the damaging effect of cytostatic drugs on hematopoiesis and lymphoid tissue].
    Gol'dberg ED; Novitskiĭ VV; Zapuskalova OB; Klimova MIu
    Vestn Akad Med Nauk SSSR; 1990; (9):52-7. PubMed ID: 2264389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of cytotoxic drugs for residual bone marrow damage.
    Trainor KJ; Morley AA
    J Natl Cancer Inst; 1976 Dec; 57(6):1237-9. PubMed ID: 1003558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy.
    Testa NG; Hendry JH; Molineux G
    Anticancer Res; 1985; 5(1):101-10. PubMed ID: 3888044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal radiation pneumonia following subclinical busulfin injury.
    Soble AR; Perry H
    AJR Am J Roentgenol; 1977 Jan; 128(1):15-8. PubMed ID: 401575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelosuppressive effects of antineoplastic drugs.
    Exp Hematol; 1985; 13 Suppl 16():1-121. PubMed ID: 3987833
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of various cytotoxic agents on bone marrow progenitor cells as measured by diffusion chamber assays.
    Squires DJ; Lamerton LF
    Br J Haematol; 1975 Jan; 29(1):31-42. PubMed ID: 1201202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Hematological Toxicities Using Mathematical Modeling.
    Fornari C; O'Connor LO; Yates JWT; Cheung SYA; Jodrell DI; Mettetal JT; Collins TA
    Clin Pharmacol Ther; 2018 Oct; 104(4):644-654. PubMed ID: 29604045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone: a novel tool for treating bone marrow depletion in cancer patients caused by chemotherapeutic drugs and ionizing radiation.
    Whitfield JF
    Cancer Lett; 2006 Nov; 244(1):8-15. PubMed ID: 16540235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do cytostatics change the histopathology of leukemias?].
    Rohmann I; Larrain C
    Rev Med Chil; 1971 Aug; 99(8):566-71. PubMed ID: 5571331
    [No Abstract]   [Full Text] [Related]  

  • 18. Antineoplastic agents and the associated myelosuppressive effects: a review.
    Barreto JN; McCullough KB; Ice LL; Smith JA
    J Pharm Pract; 2014 Oct; 27(5):440-6. PubMed ID: 25147158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospects for eradication of therapy-induced myelosuppression.
    Ventura G; Spitzer G; Hester J; Deisseroth A
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():41-2. PubMed ID: 1969309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.